跳至主要内容
临床试验/NCT06126068
NCT06126068已完成不适用

Comparison of Loading Dose Magnesium Sulphate With Prichard Regimen in the Management of Severe Preeclampsia and Eclampsia in a Resource Poor Setting, Southeast Nigeria.

Federal Teaching Hospital Abakaliki1 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2023年1月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
120
试验地点
1
主要终点
Incidence of convulsions

研究概览

简要总结

Preeclampsia/eclampsia is part of a spectrum of multi-systemic pregnancy disorder that contributes substantially to maternal and perinatal morbidity and mortality, especially in low resource setting. This study was done in Abakaliki, Ebonyi State, Southeast Nigeria.

To compare the efficacy of loading dose of magnesium sulphate with that of the Pritchard regimen in the prevention of eclampsia in severe preeclampsia and recurrent fits in eclampsia in a low resource setting.

A prospective, single blinded randomized controlled study of loading dose versus Pritchard regimens of MgSO4 at the Teaching Hospital Abakaliki. One hundred and twenty patients were recruited 60 to each arm using computer-generated numbers. Sociodemographic characteristics, efficacy and adverse effects of the drug on the mother and baby were noted.

详细描述

Background: Preeclampsia/eclampsia is part of a spectrum of multi-systemic pregnancy disorder that contributes substantially to maternal and perinatal morbidity and mortality, especially in low resource setting. This study was done in Abakaliki, Ebonyi State, Southeast Nigeria.

Objectives: To compare the efficacy of loading dose of magnesium sulphate with that of the Pritchard regimen in the prevention of eclampsia in patients with severe preeclampsia and recurrent fits in eclampsia in a low resource setting like ours.

Methods: This was a prospective, single blinded randomized controlled study of loading dose versus Pritchard regimens of MgSO4 at Alex Ekwueme Federal University Teaching Hospital Abakaliki. One hundred and twenty patients were recruited 60 to each arm using computer-generated numbers. Social demographic characteristics, efficacy and adverse effects of the drug on the mother and baby were noted. Data were collated, tabulated and analyzed using the statistical package for social sciences (SPSS) software (version 22, Chicago II, USA)

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 44 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Pregnant women with severe preeclampsia
  • Pregnant women with eclampsia
  • Signing of informed consented to participate in the study.

排除标准

  • Refusal of consent,
  • Gestational age < 28 weeks
  • Received magnesium sulphate prior to presentation
  • mild preeclampsia
  • chronic hypertension in pregnancy
  • Medical or Obstetrical complication of pregnancy.

研究组 & 干预措施

first arm - Loading dose of magnesium sulfate

Active Comparator

This arm received Loading dose of magnesium sulfate only. those that developed complication in each arm were managed according to departmental protocol.

干预措施: Use of magnesium sulfate to prevent and stop fits in pre-eclampsia and Eclampsia (Drug)

2. Pritchard regimen

Active Comparator

This arm received the full dose of magnesium sulfate regimen by Pritchard. those that developed complication in each arm were managed according to departmental protocol also.

干预措施: Use of magnesium sulfate to prevent and stop fits in pre-eclampsia and Eclampsia (Drug)

结局指标

主要结局

Incidence of convulsions

时间窗: During the intervention

percentage of fits in severe pre-eclampsia and recurrence of fits in eclampsia

次要结局

  • Drug toxicity(During the intervention)

研究者

发起方
Federal Teaching Hospital Abakaliki
申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Nwali Matthew Igwe

Principal Investigator

Federal Teaching Hospital Abakaliki

研究点 (1)

Loading locations...

相似试验